Journal for ImmunoTherapy of Cancer
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 11.7 | Q1 | 95.6% | 4.114 | Q1 | 98.6% |
| 2024 | 10.6 | Q1 | 94.0% | 4.220 | Q1 | 98.8% |
| 2023 | 10.3 | Q1 | 90.5% | 3.728 | Q1 | 98.6% |
| 2022 | 10.9 | Q1 | 88.5% | 3.403 | Q1 | 98.4% |
| 2021 | 12.5 | Q1 | 90.8% | 3.450 | Q1 | 98.4% |
| 2020 | — | — | 5.060 | Q1 | 99.0% | |
| 2019 | — | — | 4.194 | Q1 | 98.8% | |
| 2018 | — | — | 3.337 | Q1 | 98.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2051-1426
country
GBcoverage
2013-2026